Skip to content

ClearPoint Neuro CLPT Asset turnover

Asset turnover at other companies

Abbott logo
AbbottABT
0.5×-0.1×
Boston Scientific logo
Boston ScientificBSX
0.5×0.0×
IAR
Integra LifeSciencesIART
0.4×0.0×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
0.4×0.0×
Medtronic logo
MedtronicMDT
0.4×0.0×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
0.0×

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Calculated from ClearPoint Neuro’s reported figures.

Based on trailing twelve months.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's asset turnover?
ClearPoint Neuro (CLPT) reported asset turnover of 0.7× in Q1 2026.
How has ClearPoint Neuro's asset turnover changed year-over-year?
ClearPoint Neuro's asset turnover decreased by 14.6% year-over-year, from 0.8× to 0.7×.
What is the long-term trend for ClearPoint Neuro's asset turnover?
Over 5 years (2020 to 2025), ClearPoint Neuro's asset turnover has grown at a -2.7% compound annual growth rate (CAGR), from 0.6× to 0.5×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.